Sudden hearing loss - A 12 minute consultation

Leong, A.C., Fairley, J.W., & Padgham, N.D.

Department of Otolaryngology, William Harvey Hospital, Kennington Road, Willesborough Ashford, Kent, TN24 0LZ


Clinical Otolaryngology 2007 Oct;32(5) 391–394
© 2007 The Authors. Journal compilation 2007 Blackwell Publishing Limited
html version created for www.entkent.com 1 March 2008

A 38-year-old lady is referred by her GP with a history of unilateral hearing loss for 48 h.

What should you cover in the history?

The definition of sudden hearing loss is widely accepted as a sensorineural hearing loss of 30 dB or more, over at least three contiguous audiometric frequencies, that develops over 3 days or less.1–3 It must either be a new loss occurring in an ear with previously normal hearing or an incremental deterioration in an ear with pre-existing hearing loss. Although conductive hearing loss may also be sudden, with middle ear effusion as the most common cause, the term sudden hearing loss specifically refers to sudden sensorineural hearing loss.1,2 Its low incidence (eight per 100 000 persons per year), heterogeneous pathologies and spontaneous recovery (50% of patients) mean that few controlled studies exist.1–3 Comparisons are made difficult by diverse inclusion criteria and outcome measures, leading to a myriad of treatment protocols.1–3 In all, 5–10 % of sudden hearing loss cases are because of identifiable causes, which may be infectious, traumatic, neoplastic, auto-immune, toxic, circulatory, neurologic and metabolic.1,3 The overwhelming majority of cases are idiopathic, with labyrinthine viral infection, vascular insult, intracochlear membrane rupture, autoimmune inner ear disease and activation of cochlear nuclear factor kappa B (NFjB) proposed as possible causes.3

The aim of the history is to diagnose potentially treatable causes of sensorineural hearing loss, particularly ototoxicity.

What should you cover on examination?

What management should you offer?

Current literature suggests that the sooner a patient is treated, the better the recovery.1,2,4 However, the significant rate of spontaneous recovery means that those who received early treatment may well have included the subset who would have recovered spontaneously without treatment.

Good prognosis is associated with youth, male gender and a short history.8 Poor prognosis is associated with profound hearing loss, age over 60 years and the presence of vertigo.

At first visit:

More than 50 treatment regimens have been tried without good evidence of success, including surgery, cytotoxic agents, gingko biloba and magnesium.1,3 There is no high quality evidence to support systemic corticosteroid administration due to small studies thus far.11 A randomised controlled trial of oral steroid versus placebo showed promising results (73% recovery rate for patients with mid-frequency hearing loss versus 38% for the untreated controls) but its methodological quality and subgroup analysis were criticised.12

Ultimately, the risk of complications from steroids is very low, and most patients would prefer some form of treatment than none at all, to maximise hearing recovery. Super high-dose steroid therapy of a reducing course over 18 days with an initial dose of 1200 mg hydrocortisone was found to result in better hearing recovery than a similar course starting off at 600 mg, without any serious complications.13 Take caution with steroid use if the patient is diabetic, pregnant, elderly, or has a history of peptic ulcer, but no reliable data actually exists about the risks of a short course of oral steroids in these groups.3 However, high-dose corticosteroid therapy is not contra-indicated in diabetic patients with sudden hearing loss, as optimal glycaemic control is still achievable.9 Patients should be informed that aseptic necrosis of the femoral head is a very rare, idiosyncratic reaction to the use of steroids that may require total hip replacement.

The type, duration and optimum dose of steroid is unknown, but many clinicians will prescribe steroids at 1 mg/kg/day of prednisolone for 10 days in unilateral cases, and for longer periods up to a month for bilateral cases, or where auto-immune aetiology is suspected.1 Proton pump inhibitors such as lansoprazole should be prescribed in conjunction with steroids. Intratympanic steroid administration has recently been proposed as treatment for refractory sudden hearing loss where systemic steroids have failed14,15 but the efficacy and safety of intratympanic steroid therapy is unknown. Common adverse effects include pain, transient vertigo, otitis media and tympanic membrane perforation.

At follow-up.

Information sources

This article is based on evidence from a literature search performed using Entrez Pubmed on 8 March 2007, using search terms ‘sudden hearing loss’ and ‘sensorineural hearing loss’.

Conflict of Interest

None to declare.

References

1 Hughes G., Freedman M., Haberkamp T. et al. (1996) Sudden sensorineural hearing loss. Otolaryngol. Clin. North Am. 29, 393

2 Byl F. (1984) Sudden hearing loss: eight years’ experience and suggested prognostic table. Laryngoscope 94, 647–661

3 Burton M. & Harvey R. (2007) Idiopathic sudden sensorineural hearing loss. In Scott-Brown’s Otolaryngology, Gleeson, M. (ed), Chapter 131. Butterworth-Heinemann, Oxford (in press)

4 Oh J., Park K., Lee S. et al. (2007) Bilateral versus unilateral sudden sensorineural hearing loss. Otolaryngol. Head Neck Surg. 136, 87–91

5 Sauvaget E., Kici S., Petelle B. et al. (2004) Vertebrobasilar occlusive disorders presenting as sudden sensorineural hearing loss. Laryngoscope 114, 327–332

6 Matthies C. & Samii M. (1997) Management of 1000 vestibular schwannomas (acoustic neuromas). Neurosurg 40, 1–9

7 Norris C. (1988). Drugs affecting the inner ear. A review of their clinical efficacy, mechanisms of action, toxicity, and place in therapy. Drugs 36, 754–772

8 Xenellis J., Karapatsas I., Papadimitriou N. et al. (2006). Idiopathic sudden sensorineural hearing loss: prognostic factors.

9 J. Laryngol. Otol. 120, 718–724 9 Weng S., Chen Y., Hsu C. et al. (2005). Clinical features of sudden sensorineural hearing loss in diabetic patients. Laryngoscope 115, 1676–1680

10 Gagnebin J. & Maire R. (2002). Infection screening in sudden and progressive idiopathic sensorineural hearing loss: a retrospective study of 182 cases. Otol. Neurotol. 23, 160–162

11 Wei B., Mubiru S. & O’Leary S. (2006) Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst. Rev. 1, CD003998

12 Wilson W., Byl F. & Laird N. (1980) The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch. Otolaryngol. 106, 772–776

13 Aoki D., Takegoshi H. & Kikuchi S. (2006) Evaluation of superhigh-dose steroid therapy for sudden sensorineural hearing loss. Otolaryngol. Head Neck Surg. 134, 783–787

14 Marzo S. (2005) Intratympanic steroid perfusion for sudden sensorineural hearing loss. Arch. Otolaryngol. Head Neck Surg. 131, 730–732

15 Xenellis J., Papadimitriou N., Nikopoulos T. et al. (2006) Intra-tympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Otolaryngol. Head Neck Surg. 134, 940–945

16 Nechama U., Doweck R., Cohen-Kerem R. et al. (2003) Acyclovir in the treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol. Head Neck Surg. 128, 544–549

17 Wilkins S., Mattox D. and Lyles A. (1987) Evaluation of a ‘shotgun’ regimen for sudden hearing loss. Otolayngol. Head Neck Surg. 97, 474–480

18 Bennett M., Kertesz T. & Yeung P. (2005) Hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss and tinnitus: a systematic review of randomised controlled trials.

19 J. Laryngol. Otol. 119, 791–798 19 Ito S., Fuse T., Yokota M. et al. (2002) Prognosis is predicted by early hearing improvement in patients with idiopathic sudden sensorineural hearing loss. Clin. Otolaryngol. 27, 501–504

20 Baguley D., Bird J., Humphriss R. et al. (2006) The evidence base for the application of contralateral bone anchored hearing aids in acquired sensorineural hearing loss in adults. Clin. Otolaryngol. 31, 6–14

21 Furuhashi A., Matsuda K., Asahi K. et al. (2002) Sudden deafness: longterm follow-up and recurrence. Clin. Otolaryngol. 27, 458–463
© 2007 The Authors. Journal compilation 2007 Blackwell Publishing Limited, Clinical Otolaryngology, Oct;32(5) 391–394.
html version created for www.entkent.com 1 March 2008